×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Pr Jérôme Alexandre & Dr Enora Laas


Cas clinique :  

18:30
Mise en pratique des données de DESKTOP III :

 - Recommandations de surveillance à la fin du traitement initial - Pr Jérôme Alexandre

- Nouvelles stratégies chirurgicales en rechute - Dr Enora Laas
 
19:10
Espérance de vie des patientes sous iPARP : quels nouveaux enjeux en maintenance ?
Dr Manuel Rodrigues
 
19:35
Quelles possibilités de suivi des patientes sous iPARP en pratique courante ?
Mme Pascale Dielenseger
19:45
Discussion Q&A
 

 

Shooting date : 2021-06-22
Last update : 2021-06-29
1 comment
Join the Discussion
  • l D. quand pourra-t-on avoir le replay? Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, September 10th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, September 10th 2024 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, September 10th 2024 from 10am to 11:30am (GMT+2)
    New York : Tuesday, September 10th 2024 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, September 10th 2024 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, September 10th 2024 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, September 10th 2024 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, September 10th 2024 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, September 10th 2024 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 10th 2024 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, September 11th 2024 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, September 11th 2024 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, September 11th 2024 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, September 11th 2024 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, September 11th 2024 from 06am to 07:30am (GMT+2)

    iPARP et cancer de l’ovaire : quand et pour qui ?

    Share
    Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, April 12th 2022 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, April 12th 2022 from 10am to 11:30am (GMT+2)
    New York : Tuesday, April 12th 2022 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, April 12th 2022 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, April 12th 2022 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, April 12th 2022 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, April 12th 2022 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 12th 2022 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, April 13th 2022 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, April 13th 2022 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, April 13th 2022 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, April 13th 2022 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, April 13th 2022 from 06am to 07:30am (GMT+2)

    Cancers séreux de bas grade

    Share
    Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Monday, November 28th 2022 from 07am to 08:30am (GMT+1)
    San Francisco : Monday, November 28th 2022 from 09am to 10:30am (GMT+1)
    New York : Monday, November 28th 2022 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Monday, November 28th 2022 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Istanbul : Monday, November 28th 2022 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Monday, November 28th 2022 from 09pm to 10:30pm (GMT+1)
    Bangkok : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
    Shanghai : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
    Tokyo : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
    Sydney : Tuesday, November 29th 2022 from 03am to 04:30am (GMT+1)
    Wellington : Tuesday, November 29th 2022 from 05am to 06:30am (GMT+1)

    Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

    Share
    Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, September 19th 2023 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, September 19th 2023 from 10am to 11:30am (GMT+2)
    New York : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, September 19th 2023 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 19th 2023 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, September 20th 2023 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, September 20th 2023 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, September 20th 2023 from 06am to 07:30am (GMT+2)

    Prise en charge des carcinomes séreux de bas grade en 2023

    Share
    Scroll Up